SUS (Stenfilcon A) Contact Lens
FDA 510(k)Class II (US FDA 510(k))
Identifiers
- 510(k) Number
- K131378 FDA 510(k)
- FDA Product Code
- LPL FDA 510(k)
Classification
- Device Class
- Class II FDA 510(k)
- Legislation / Framework
- 21 CFR Part 886.5925 FDA 510(k)
- Regulation Number
- 886.5925 FDA 510(k)
- Advisory Committee
- Ophthalmic FDA 510(k)
- FDA Decision
- SESE Substantially Equivalent FDA 510(k)
The SUS (Stenfilcon A) Contact Lens is a Soft Contact Lens, Daily Wear (product code LPL), designed for vision correction. It is classified as a silicone hydrogel lens with a water content of 54% and a material composition of 46% stenfilcon A. This device is intended for single-use, providing clear and comfortable vision correction for daily wear applications.
The lens is supplied sterile in buffered saline and features a blue visibility tint (Reactive Blue #246) and a UV blocker. Available in aspherical, toric, multifocal, and multifocal toric designs, it is intended for ophthalmic use. The device holds FDA 510(k) clearance (K131378) under the regulatory classification of Class II – Special Controls, with a decision date of August 30, 2013.
This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: K131378 FDA 510 (k) - SUS (STENFILCON A) CONTACT LENS, SUS (STENFILCON A) CONTACT LENS (K131378) - Innolitics, PDF K131378 - Sus (Stenfilcon A) Contact Lens
Authorization Coverage (1 country)
Regulatory Authorizations
FDA_510K
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA 510(k) | United States | FDA_510K | K131378 | Class II | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Coopervision Inc.
- FDA Applicant
- CooperVision, Inc.
Sources (1)
- FDA 510(k) K131378 24 fields · synced Sep 19, 2026